Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics.
D000284:Administration, Oral; D000577:Amides / Q000008:administration & dosage / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001590:Benztropine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005998:Glycine; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007930:Leucine; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009842:Oligopeptides / Q000008:administration & dosage / Q000494:pharmacology*; D010095:Oxotremorine / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology*; D011392:Proline; D012601:Scopolamine / Q000494:pharmacology; D013997:Time Factors; D014282:Trihexyphenidyl / Q000494:pharmacology
D000577:Amides; D009842:Oligopeptides; D010276:Parasympatholytics; D001590:Benztropine; D010095:Oxotremorine; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D011392:Proline; D012601:Scopolamine; D007930:Leucine; D005998:Glycine